Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Arranta Bio
AddedFeb 15, 2024
UpdatedJun 28, 2026
Arranta Bio

Arranta Bio

Series B

Arranta Bio: Contract development and manufacturing of live biotherapeutic products.

HQ
Watertown, MA, US
Founded
2019
Overview
Compare
Fundraising
Employees

Arranta Bio focuses on the contract development and manufacturing of live biotherapeutic products (LBPs) for clinical and commercial supply. The company aims to advance the development and production of innovative biotherapeutics, targeting the growing market for microbiome-based treatments.

Arranta Bio has achieved significant milestones in the biotherapeutics sector, establishing itself as a key player in the industry. The company is known for its state-of-the-art facilities and expertise in cGMP manufacturing, contributing to the successful commercialization of several LBPs.

Arranta Bio - Similar Companies

Petri Bio logo

Petri Bio

petribio.com

BioPlx logo

BioPlx

Arrivo BioVentures logo

Arrivo BioVentures

arrivobio.com

AvantBio logo

AvantBio

Larrk Bio logo

Larrk Bio

Lucaspye BIO logo

Lucaspye BIO

lucaspyebio.com

Bien-Etre Labs logo

Bien-Etre Labs

ResBiotic logo

ResBiotic

resbiotic.com

Locanabio logo

Locanabio

Rbio logo

Rbio

rbio.online

MarvelBiome logo

MarvelBiome

marvelbiome.com

Adventa Bioscience logo

Adventa Bioscience

GentiBio logo

GentiBio

gentibio.com

Arc Bio logo

Arc Bio

cantatabio.com

Luca Biologics logo

Luca Biologics

seedhealth.com

Arranta Bio - Quick Facts

Who are Arranta Bio's competitors?

Companies similar to Arranta Bio include Petri Bio, BioPlx, Arrivo BioVentures and AvantBio.

When was Arranta Bio founded?

Arranta Bio was founded in 2019.

Where is Arranta Bio's headquarters located?

Arranta Bio's headquarters is located in Watertown, MA, US.

How much has Arranta Bio raised to-date?

As of Mar 8, 2021, Arranta Bio has raised a total of $82M (USD).

How many employees does Arranta Bio have?

Arranta Bio has 102 employees as of Feb 4, 2024.

Arranta Bio - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Services
  • Software
Customer
  • Enterprise
Main Product
  • Biotherapeutics
  • Manufacturing
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software